Disclosed are methods of treating erosive polyarthritis comprising administering a TNFalpha antibody, or antigen-binding portion thereof. The invention also describes a method for testing the efficacy of a TNFo antibody, or antigen-binding portion thereof, for the treatment of erosive polyarthritis